Index of artpub/2020/pmc_33138866/

Garrido-Castro, Ana C
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
2020
https://ddd.uab.cat/record/238636